These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 37283506)
1. Tumor-Generated Reactive Oxygen Species Storm for High-Performance Ferroptosis Therapy. Huang L; Zhu J; Xiong W; Feng J; Yang J; Lu X; Lu Y; Zhang Q; Yi P; Feng Y; Guo S; Qiu X; Xu Y; Shen Z ACS Nano; 2023 Jun; 17(12):11492-11506. PubMed ID: 37283506 [TBL] [Abstract][Full Text] [Related]
2. A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling. Huang L; Feng J; Zhu J; Yang J; Xiong W; Lu X; Chen S; Yang S; Li Y; Xu Y; Shen Z Adv Healthc Mater; 2023 Jul; 12(18):e2203362. PubMed ID: 36893770 [TBL] [Abstract][Full Text] [Related]
3. Self-Assembled Copper-Based Nanoparticles for Glutathione Activated and Enzymatic Cascade-Enhanced Ferroptosis and Immunotherapy in Cancer Treatment. Song WF; Zeng JY; Ji P; Han ZY; Sun YX; Zhang XZ Small; 2023 Aug; 19(35):e2301148. PubMed ID: 37118853 [TBL] [Abstract][Full Text] [Related]
4. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R Acta Biomater; 2024 Jul; 183():252-263. PubMed ID: 38801869 [TBL] [Abstract][Full Text] [Related]
5. A ROS storm generating nanocomposite for enhanced chemodynamic therapy through H Li Y; Wang J; Zhu T; Zhan Y; Tang X; Xi J; Zhu X; Zhang Y; Liu J Nanoscale; 2024 May; 16(17):8479-8494. PubMed ID: 38590261 [TBL] [Abstract][Full Text] [Related]
6. Cycloacceleration of Reactive Oxygen Species Generation Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for Tumor Ferroptosis Therapy. Zhou H; Lu X; Du C; Zhou Z; Feng J; Liang Z; Xu Y; Qiu X; Shen Z Small; 2022 Sep; 18(35):e2202705. PubMed ID: 35923138 [TBL] [Abstract][Full Text] [Related]
7. Chemodynamic therapy combined with endogenous ferroptosis based on "sea urchin-like" copper sulfide hydrogel for enhancing anti-tumor efficacy. Li S; Wang B; Tao J; Dong Y; Wang T; Zhao X; Jiang T; Zhang L; Yang H Int J Pharm; 2024 Jul; 660():124330. PubMed ID: 38866081 [TBL] [Abstract][Full Text] [Related]
8. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis. Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124 [TBL] [Abstract][Full Text] [Related]
9. A strategy of "adding fuel to the flames" enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy. Huang L; Zhu J; Wu G; Xiong W; Feng J; Yan C; Yang J; Li Z; Fan Q; Ren B; Li Y; Chen C; Yu X; Shen Z Biomaterials; 2024 Dec; 311():122701. PubMed ID: 38981152 [TBL] [Abstract][Full Text] [Related]
11. Enzyme-like copper-encapsulating magnetic nanoassemblies for switchable T1-weighted MRI and potentiating chemo-/photo-dynamic therapy. Li T; Rao B; Xu D; Zhou J; Sun W; Zhi X; Zhang C; Cui D; Xu H Acta Biomater; 2022 Nov; 153():431-441. PubMed ID: 36174937 [TBL] [Abstract][Full Text] [Related]
12. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy. Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338 [TBL] [Abstract][Full Text] [Related]
13. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy. Zou W; Gao F; Meng Z; Cai X; Chen W; Zheng Y; Ying T; Wang L; Wu J J Colloid Interface Sci; 2024 Jun; 663():787-800. PubMed ID: 38442520 [TBL] [Abstract][Full Text] [Related]
14. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion. Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414 [TBL] [Abstract][Full Text] [Related]
15. Nanocatalytic theranostics with intracellular mutual promotion for ferroptosis and chemo-photothermal therapy. Zhang M; Chen Y; Wang Q; Li C; Yuan C; Lu J; Luo Y; Liu X J Colloid Interface Sci; 2024 Mar; 657():619-631. PubMed ID: 38071811 [TBL] [Abstract][Full Text] [Related]
16. MRI-Guided Tumor Therapy Based on Synergy of Ferroptosis, Immunosuppression Reversal and Disulfidptosis. Guo S; Li Z; Zhou R; Feng J; Huang L; Ren B; Zhu J; Huang Y; Wu G; Cai H; Zhang Q; Ke Y; Guan T; Chen P; Xu Y; Yan C; Ou C; Shen Z Small; 2024 Jul; 20(29):e2309842. PubMed ID: 38431935 [TBL] [Abstract][Full Text] [Related]
17. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W Adv Healthc Mater; 2024 Jun; 13(16):e2303568. PubMed ID: 38319010 [TBL] [Abstract][Full Text] [Related]
18. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy. Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781 [TBL] [Abstract][Full Text] [Related]
19. Boosting Reactive Oxygen Species Generation with a Dual-Catalytic Nanomedicine for Enhanced Tumor Nanocatalytic Therapy. Su G; Xu H; Zhou F; Gong X; Tan S; He Y ACS Appl Mater Interfaces; 2023 Dec; 15(51):59175-59188. PubMed ID: 38095444 [TBL] [Abstract][Full Text] [Related]
20. Nanotrains of DNA Copper Nanoclusters That Triggered a Cascade Fenton-Like Reaction and Glutathione Depletion to Doubly Enhance Chemodynamic Therapy. Li Q; Wang F; Shi L; Tang Q; Li B; Wang X; Jin Y ACS Appl Mater Interfaces; 2022 Aug; 14(33):37280-37290. PubMed ID: 35968633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]